Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Purpose The aim of this study is to evaluate the natural history of untreated pancreatic cancer, with a particular emphasis on the growth rate of primary tumor and development of metastatic disease.Methods One hundred patients with histologically proven pancreatic ductal adenocarcinoma examined with at least two CT scans with no intervening treatment were included. Tumor diameters and volumes were measured in CT scans and tumor growth rates and volume doubling times (VDTs) were calculated. The relationship between initial tumor size, growth rate, and distant metastasis development were investigated.Results Included tumors were 1.0-6.2 cm (mean, 2.9 ± 1.3 cm) in diameter and 5.5-1225.9 cm 3 (mean, 120.6 ± 158.9 cm 3) in volume at the initial CT. Tumor growth rates were -0.4 to 19.9 cm/year (mean, 4.2 ± 3.8 cm/year) in diameter, and 11.1-13,321.5 cm 3/year (mean, 727.8 ± 1609.5 cm 3/year) in volume corresponding to VDT of 20.0-976.8 days (mean, 132.3 ± 132.1 days). The growth rate was significantly associated with the initial diameter and volume (p < 0.001). The development of distant metastasis was significantly associated with initial diameter (p < 0.05), volume (p = 0.015), and volume growth rate (p = 0.002).Conclusions The growth rate and VDTs of untreated pancreatic cancers varied widely, from less than a month to more than 4 years, positively associated with tumor size. The small tumors tend to grow slowly and have low risk for developing metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recognizable quantities fall in clinically measured ranges: the inferred tumor doubling time of 130 days is consistent with PDAC volume‐doubling‐time measurements [27, 28].”
From Structured Schemas for Provenance‐Rich, LLM ‐Assisted QSP Model Calibration (2026) · cites this paper as [27]
In the citing paper
“the inferred tumor doubling time of ∼130 days is consistent with PDAC volume-doubling-time measurements27,28.”
From Structured Schemas for Provenance-Rich, LLM-Assisted QSP Model Calibration (2026) · cites this paper as [27]
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Spencer, P. M., Cameron, J. L., & Lin, L. (2000) · Cited by 7,202
Li, D., Xie, K., Wolff, R., & Abbruzzese, J. L. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15841-8 · Cited by 1,719
Integrated PET/CT: Current Applications and Future Directions
von Schulthess, G. K., Steinert, H. C., & Hany, T. F. (2006) · Radiology · doi:10.1148/radiol.2382041977 · Cited by 619
A biomathematical approach to clinical tumor growth
Schwartz, M. (1961) · Cancer · doi:10.1002/1097-0142(196111/12)14:6<1272::aid-cncr2820140618>3.0.co;2-h · Cited by 548
Bilimoria, K. Y., Bentrem, D. J., Ko, C. Y., Ritchey, J., Stewart, A. K., Winchester, D. P., & Talamonti, M. S. (2007) · Cancer · doi:10.1002/cncr.22852 · Cited by 427
Collective Review of Small Carcinomas of the Pancreas
TSUCHIYA, R., TOMIOKA, T., IZAWA, K., NODA, T., YAMAMOTO, K., TSUNODA, T., HARADA, N., YAMAGUCHI, T., YOSHINO, R., MIYAMOTO, T., et al. (1986) · Annals of Surgery · doi:10.1097/00000658-198601000-00013 · Cited by 348
Semelka, R. C., Brown, E. D., Ascher, S. M., Patt, R. H., Bagley, A. S., Li, W., Edelman, R. R., Shoenut, J. P., & Brown, J. J. (1994) · Radiology · doi:10.1148/radiology.192.2.8029404 · Cited by 309
Cited by
Why is pancreatic cancer so deadly? The pathologist's view
Hruban, R. H., Gaida, M. M., Thompson, E., Hong, S., Noë, M., Brosens, L. A., Jongepier, M., Offerhaus, G. J. A., & Wood, L. D. (2019) · The Journal of Pathology · doi:10.1002/path.5260 · Cited by 115
Factors associated with missed and misinterpreted cases of pancreatic ductal adenocarcinoma
Kang, J. D., Clarke, S. E., & Costa, A. F. (2021) · European Radiology · doi:10.1007/s00330-020-07307-5 · Cited by 84
Lukács, G., Kov́acs, Á., Csanádi, M., Moizs, M., Repa, I., Kaló, Z., Vokó, Z., & Pitter, J. G. (2019) · Cancer Management and Research · doi:10.2147/cmar.s221427 · Cited by 47
Jones, C. M., Radhakrishna, G., Aitken, K. L., Bridgewater, J. A., Corrie, P. G., Eatock, M. M., Goody, R. B., Ghaneh, P., Good, J. S., Grose, D. B., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0980-x · Cited by 29
Earlier Diagnosis of Pancreatic Cancer: Is It Possible?
Koltai, T. (2023) · Cancers · doi:10.3390/cancers15184430 · Cited by 24
Metadata
- Authors
- Ahn, S. J., Choi, S. J., & Kim, H. S.
- Affiliations
- Seoul National University (KR)
- Gachon University Gil Medical Center (KR)
- Corresponding author
- Choi, Seung Joon
- Venue
- Journal of Gastrointestinal Cancer
- Published
- 2016-10-04
- Volume
- 48
- Issue
- 2
- Pages
- 164-169
- ISSN
- 1941-6628 (ISSN-L)
- 1941-6636
- OpenAlex
- W2529166300
- Cited by
- 32
- References
- 27
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 2 · 2023: 4 · 2022: 7 · 2021: 3 · 2020: 3 · 2019: 3 · 2018: 2 · 2017: 1
- FWCI
- 1.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Gastrointestinal Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › MRI in cancer diagnosis
- Keywords
- pancreatic ductal adenocarcinoma, tumor growth rate, volume doubling time, tumor progression, distant metastasis, natural history (disease), tumor size, tumor volume, multidetector computed tomography
- MeSH terms
- Adenocarcinoma, Adult, Aged, Aged, 80 and over, Female, Humans, Liver Neoplasms, Lung Neoplasms, Lymphatic Metastasis, Magnetic Resonance Imaging, Male, Middle Aged, Pancreatic Neoplasms, Peritoneal Neoplasms, Retrospective Studies, Time Factors, Disease Progression, Carcinoma, Pancreatic Ductal, Tumor Burden, Multidetector Computed Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography. https://app.cochat.ai/papers/10.1007/s12029-016-9876-7
- The paper
- Ahn, S. J., Choi, S. J., & Kim, H. S. (2017). Time to Progression of Pancreatic Cancer: Evaluation with Multi-Detector Computed Tomography. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-016-9876-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.